AU2002252950A1 - Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis - Google Patents
Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesisInfo
- Publication number
- AU2002252950A1 AU2002252950A1 AU2002252950A AU2002252950A AU2002252950A1 AU 2002252950 A1 AU2002252950 A1 AU 2002252950A1 AU 2002252950 A AU2002252950 A AU 2002252950A AU 2002252950 A AU2002252950 A AU 2002252950A AU 2002252950 A1 AU2002252950 A1 AU 2002252950A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- protein kinase
- agents
- tumour cells
- stimulating angiogenesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10109883 | 2001-02-22 | ||
DE10109883.9 | 2001-02-22 | ||
DE10117266 | 2001-03-30 | ||
DE10117266.4 | 2001-03-30 | ||
PCT/DE2002/000652 WO2002066021A2 (en) | 2001-02-22 | 2002-02-21 | Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002252950A1 true AU2002252950A1 (en) | 2002-09-04 |
Family
ID=26008653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002252950A Abandoned AU2002252950A1 (en) | 2001-02-22 | 2002-02-21 | Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002252950A1 (en) |
DE (4) | DE10290563D2 (en) |
WO (2) | WO2002066027A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10147088A1 (en) * | 2001-09-25 | 2003-04-17 | Medinnova Ges Med Innovationen | Use of active substances for the prophylaxis and / or therapy of diseases which are associated with cell growth disorders and test system for finding such active substances |
ES2245612B1 (en) * | 2004-06-29 | 2007-08-16 | Universidad De Barcelona | NEW THERAPEUTIC USE OF FORMOTEROL. |
ITFI20050031A1 (en) * | 2005-02-21 | 2006-08-22 | Stefan Coccoloni | A PHARMACEUTICAL COMPOSITION TO PREVENT THE AGING AND THE RISING OF VASCULAR, NEOPLASTIC, CUTANEOUS AND PILIFEROUS DISEASES |
GB0625270D0 (en) * | 2006-12-19 | 2007-01-31 | Univ Leicester | Angiogenesis |
US9066974B1 (en) | 2010-11-13 | 2015-06-30 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
US9095606B1 (en) | 2010-11-13 | 2015-08-04 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9003057D0 (en) * | 1990-09-26 | 1990-09-26 | Astra Ab | NEW PROCESS |
US5135954A (en) * | 1991-05-24 | 1992-08-04 | The Regents Of The University Of California | Use of formoterol for treatment of tissue injury |
-
2002
- 2002-02-21 WO PCT/DE2002/000653 patent/WO2002066027A1/en not_active Application Discontinuation
- 2002-02-21 DE DE10290563T patent/DE10290563D2/en not_active Expired - Fee Related
- 2002-02-21 DE DE10207881A patent/DE10207881A1/en not_active Withdrawn
- 2002-02-21 WO PCT/DE2002/000652 patent/WO2002066021A2/en not_active Application Discontinuation
- 2002-02-21 DE DE10207882A patent/DE10207882A1/en not_active Withdrawn
- 2002-02-21 AU AU2002252950A patent/AU2002252950A1/en not_active Abandoned
- 2002-02-21 DE DE10290562T patent/DE10290562D2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE10207881A1 (en) | 2003-02-13 |
DE10290562D2 (en) | 2004-04-29 |
WO2002066021A2 (en) | 2002-08-29 |
DE10290563D2 (en) | 2004-04-29 |
WO2002066027A1 (en) | 2002-08-29 |
DE10207882A1 (en) | 2003-02-27 |
WO2002066021A3 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2728201A (en) | 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors | |
AU2002310187A1 (en) | Inhibitors of protein kinase for the treatment of disease | |
IL148719A0 (en) | Kinase inhibitors as therapeutic agents | |
PL375447A1 (en) | Protein kinase inhibitors and uses thereof | |
IL146094A0 (en) | Diaminothiazoles and their use for inhibiting protein kinases | |
HUP0202713A3 (en) | Pteridinones as kinase inhibitors | |
AU2002334355A1 (en) | Protein tyrosine kinase inhibitors | |
AU2002213485A1 (en) | Inhibitors of protein kinases | |
AP2002002392A0 (en) | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use | |
AU2003259749A1 (en) | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors | |
AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
AU2495200A (en) | Compositions and methods for the treatment of tumor | |
AU2001270260A1 (en) | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors | |
AU2003256410A1 (en) | COMBINATION THERAPY WITH p38 MAP KINASE INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS | |
AU2002953255A0 (en) | Protein kinase inhibitors | |
AU2001245987A1 (en) | Compositions and methods for gene therapy | |
AU2576501A (en) | Protein kinase inhibitors | |
AU1189201A (en) | Therapeutic compositions including protein kinase c inhibitors | |
AU2002237657A1 (en) | Indole-type inhibitors of p38 kinase | |
AU2002252950A1 (en) | Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis | |
AUPS251502A0 (en) | Protein kinase inhibitors | |
AU2591299A (en) | Human protein kinase c inhibitor | |
AU2001279090A1 (en) | Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |